Give Now

Gratitude inspires joining
together to do more

Leading Edge Medicine: Cancer Research

Behind the Breakthroughs: 
How Cancer Research Is Changing Lives

In a dynamic panel conversation, Drs. Lannis Hall, Sheila Stewart, and Premal Thaker will discuss their individual bodies of research and how they are significantly improving outcomes for patients with cancer and proactively addressing health disparities. Join us to learn about how research scientists and physicians accelerate innovation right here in St. Louis.

WHEN

Wednesday, March 26, 2025
5:30 p.m. Reception
6:00 p.m. Program begins, followed by a Q&A
(Offering both in-person and livestream options)

WHERE

VUE 17
1034 S. Brentwood Blvd, 17th Floor
St. Louis, Missouri 63117

FeaturingDrs. Sheila Stewart, Lannis Hall, and Premal Thaker

Sheila A. Stewart, PhD

Gerty T. Cori Professor 
Professor of Cell Biology & Physiology 
Professor of Medicine 
Vice Chair of Cell Biology and Physiology 
Associate Director for Basic Sciences, Siteman Cancer Center 
ICCE Institute 

Presenting her research focused on understanding how age-related changes in noncancerous cells participate in cancer development and how this study led to the identification of a new therapeutic target. 

Lannis Hall, MD, MPH

Associate Professor of Clinical Radiation Oncology
Director of Radiation Oncology,  Barnes-Jewish St. Peter’s Hospital 
Siteman Cancer Center, Director of Diversity and Inclusion in Research Clinical Trials Leader,   
Program to Eliminate Cancer Disparities 
Washington University School of Medicine  

Presenting her work to address health  disparities through improved diversity in  clinical trials, as well as complementary  community-based programs to help identify cancer earlier and treat it sooner. 

Premal H. Thaker, MD

David & Lynn Mutch Distinguished Professor of Ob/Gyn
Chief of Gynecologic Oncology, Interim Director of Gynecologic Oncology Clinical Research
Professor in Gynecologic Oncology
Washington University School of Medicine

Presenting her research related to ovarian  and endometrial cancer trials and how  immunotherapies are filling an unmet need in the drastically under-researched area  of gynecologic cancer.